Equity Brief
$POET
Public-view summary · Not verified holdings
On Aug 13, 2026, the author disclosed a small position, citing ample cash and low enterprise value, but called POET a wait-for-customers story rather than a clear long thesis like $AAOI.
No formal target price was provided. A scenario based on 2027 capacity and a $125-$200 ASP implies up to roughly $1.8B of revenue at a $150 ASP, but there is no evidence that demand can fill the capacity.
An optical-engine and photonic-packaging platform between upstream lasers and high-speed transceivers/data-center interconnects.
The author disclosed a small POET position, citing roughly $830M in cash and low enterprise value, but said customer demand is unclear and the thesis is less direct than AAOI.
Representative public evidence supporting the current view.
Market Chart
$POET
Core Thesis
THESISPOET is a high-risk, small-position option on optical-engine capacity. The author values its low enterprise value, 2027 capacity target, and ability to fund acquisitions or secure EML/CW supply, but sees insufficient customer demand to fill that capacity today.
Catalyst Timeline
CATALYSTSLatest Stance
LATESTOn Aug 13, 2026, the author disclosed a small position, citing ample cash and low enterprise value, but called POET a wait-for-customers story rather than a clear long thesis like $AAOI.
Representative Tweets
EVIDENCEThe author disclosed a small POET position, citing roughly $830M in cash and low enterprise value, but said customer demand is unclear and the thesis is less direct than AAOI.
POET is a 'Waiting for Customers' story: cash and supply capacity are available, but demand visibility is low.
A new $2.3M purchase order was noted, but the author still wants to wait for the earnings call.
All Related Tweets
99 TWEETS@Papsytwinz Uhh nothing really too interesting aside from a new $2.3M purchase order for $POET Will need to wait for earnings call.
@dra99aso I usually just post research along the way as new news comes out (eg. Lumilens $5.5B valuation announcement + hyperscaler contracts). But I'll drop it in disclosures if I have a position on something like $POET or $SMCI earlier. Maybe I'll do a roundup TLDR later.
If I had to categorize it: $SIVE = Waiting for Revenue Conversion Tons of hyperscaler suppliers + demand visibility for the CW DFB. How do markets want to price in or assign a premium on the waiting game for 1.6T H1 2027 to CPO scale up for H2 2027? $AAOI = Waiting for Capacity Execution Extreme demand visibility for transceivers. Can they ramp up capacity to meet their $471m/month projections? $POET = Waiting for Customers Too much cash relative to MC + heavily funded supply chain capacity setup, little demand visbility.
Okay here's my take on $POET, since apparently people are celebrating on the subreddit that I took small positions. - I have 0 idea. ZERO. How they convinced shareholders to allow them dilute SO MUCH to the point: They have an absurd ~$830m cash on hand now. And my guess is that they're close to done, since I would be in disbelief if they needed more. So now... they have ~$830m to grow their business like M&A, and EV actually dropped really low recently (eg. $1.25B MC vs. $830m cash on hand), that I thought it was compelling to take a risk. - Annualized production capacity target is 12M optical engines/year for 2027, which is pretty absurd ramp. Need to do more research into ASP for Poet's products, but maybe $125-$200? So at ~$150 ASP, $1.8B revenue ceiling. But they're like inverse AAOI right now: no visible demand to fill all that capacity. Aside from Lumilens, which is now a highly valued hyperscaler supplier (probably Amazon or Microsoft), with billions in customer agreements. The interesting thing is if Poet signed prepayment EML agreements with players like Mitsubishi, or CW agreements with Sivers behind the scenes with that balance sheet. And given the current bottleneck, players might use Poet as a workaround for supply procurement. But basically, you have a super cash-rich company with a ton of capacity coming online. And they're not really disappearing anytime soon with their financials. I don't quite think it's as technically defensible compared to upstream laser chokepoints with something like $SIVE around the same valuation in terms of technical moat for CW lasers vs. OE packaging side. As you've seen recently with Celestial and Poet. But maybe... there's a chance some hyperscaler or downstream company announces a volume agreement sometime in the future. and $POET takes off. And they do have the supply chain setup for ramp with that. That's the risk I ended up taking, but it's not exactly a clear as day long for me like $AAOI.
My main takeaway was that your merchant CW laser suppliers seem to be EXTREMELY IMPORTANT now. But TLDR of $COHR earnings: "given the demand that we see in our DC business with transceivers, I don’t see any time in the near future where we would be selling indium phosphide lasers externally" - Ton more value placed on companies that sell InP lasers externally if $AAOI can't doesn't enough capacity for first gen-CPO deployments, $COHR not selling externally... I guess that's why $MTSI said a ton of customers are approaching them with urgency for InP CW DFB lasers (and they dont even have meaningful capacity coming online until EOY 2027) $AAOI -> Internal $COHR -> Internal Buyers -> fewer places to look for capacity. "Our backlog now extends out, fiscal 2027 is basically completely booked out. We are booked really through the end of calendar 2027" [ Massive massive demand visibility] - Coherent also mentioned LTAs spanning end of decade. So this kinda reinforces what $POET CEO said at their AGM that the "big 3" are fully sold out next 2 years. "we’re not constrained in the assembly and test capacity right now. We’re really just constrained by the ramp of the indium phosphide production" - Just for the bottleneck bros in terms of assembly/test not a bottleneck. "absolutely no push-out of CPO demand. In fact, it has been the opposite. We have seen demand increase and request from customers’ demand getting pulled in" "we continue to expect revenue from CPO for scale-up applications to start to flow in the second half of calendar 2027" - Big read through on other CPO players for scale up if $LITE, $COHR reaffirm revenue from CPO scale up coming h2027. - "quarterly revenue exceeding $3 billion by the end of fiscal 2027" - $COHR revenue go brrr So for regular numbers it's: - $2.046B revenue (+13.3% Q/Q, +33.8% Y/Y), main revenue ramp looks to be happening entering Q4 into 2027 - Non-GAAP gross margins: 40.2% Next quarter guide is: - Revenue: $2.2–$2.4B revenue - Non-GAAP gross margins: 39.5-41.5% Basically: $1.69B -> $1.81B -> $2.05B -> ~$2.30B -> $3.0B (end of FY 2027) ~39% -> 39.6% -> 40.2% -> ~40.5% (gross margins) For operating margins: 18.0% -> 19.5% -> 19.9% -> 20.3% -> 21.8% Little less impressed compared to $LITE margin growth in terms of profitability, but revenue scale for $COHR growing rapidly.
- Because newer 1.6T optical transceivers and CPO volumes haven't ramped yet. $SIVE is targeting all the next generation optical shifts. This comes from a misunderstanding of architectural shifts, you won't get 9 figure revenue in 2024 if customer CPO scale up deployments start in 2028. - $SIVE has 130+ employees and if I remember correctly, 1/4th to 1/3d were PHDs. Lot of what they do is IP and they use Win Semi, external foundries for volume ramp. If they did assembly like $FN or $COHR, you would see employee count balloon. Not quite sure why you say a customer supplying to $JBL, $GFS, Ayar, $POET, and many other hyperscaler suppliers is a hopeless case. Probably one of the most unique ones I've seen.
@NicolaRussoIT Not as familiar with adoption read through with $ANET XPO MSA (ik $MSFT has been the most openly supportive).. so can't really give a good answer to implications on other players like $POET. https://t.co/Xi6zrmo5ha
I think we already got too many hints from $AAOI earnings about demand 20-40% imbalance for optical transivers with lasers as a bottleneck. And $POET stating big 3 are completely sold out of capacity next 2 years during their AGM. I don’t give earnings up or down predictions since it’s a coin flip most of the time. But I can say that a lot of pricing happens before earnings, unless there’s something very unexpected. Regardless I expect $LITE earnings to come out really strong, and I primary use it as a read through for your other laser players.
I’m actually kinda curious about $SIVE securing more foundry allocation given widespread CW DFB shortages now. Since I’m pretty confident it sells out once qualifications go into volume ramp. But aside from that > reaffirm demand/supply imbalance from other earnings like $MTSI / $AAOI helps > new development/qualifications mentioned in previous earnings with pluggable players, probably most material > Progress with $JBL, ~ $AEVA, $POET, $GFS or other opportunities, maybe initial POs would be nice. > Nasdaq listing update reiterated (we already got updates it’s planned completion next few quarters). I still place that on priority personally since it unlocks more funding for their M&A efforts, hopefully down the pluggable stack. I think the revenue inflection starts around H1 2027, so current revenue/profit numbers are not very material. An $AAOI statement like anything we make we expect to be sold in 2028 or something would be kinda goated.
Earlier today, optical interconnect company Lumilens "emerges from stealth" at a $5.5B valuation, after raising $700m. Just as a recap from $POET / $SIVE Linkedin OSINT mapping I shared earlier, Lumilens was supplying a top 3 hyperscaler customer. So we got confirmation of that a month later, along with the material figure that Lumilens has a "multi-billion-dollar customer agreement". And just for reference, $POET has existing contracts with Lumilens ($50m purchase order, up to $500m) + contracts with $SIVE (depending on product lines). I actually took tiny positions in POET again after reading this news, since it finally gives them visibility into extremely well funded hyperscaler suppliers (on top of Poet's really large balance sheet). But TLDR: > Lumilens around similar (or even higher) valuations as Lightmatter/Ayar, bigger than markets thought with hyperscaler customers. > nice read through upstream on $POET (derisking) / $SIVE. > Great for optical valuations in general, seeing a company go to $5.5B in 2 years.
Now that I think of it more, $POET optical interposer piece is actually a little more material than I thought with $SIVE. Originally the wording was "readiness" for EOY 2026. But $POET upgraded that wording, by stating "production" with Sivers lasers projected EOY 2026. So a volume orders from across $JBL to $POET, should hit in H1 2027. Which makes a bit of sense, since Sivers did raise an institutional oversubscribed round for future mass production. On a side note, can't believe it's already August and 5 months left until 2027... Which was my inflection window for glass substrates, CPO, 800v, and new architectures to ramp.
@A22GEO The $POET optical interposer piece is actually a very interesting update and talks about $SIVE. Since it's a material timeline upgrade wording for "production" EOY 2026, for Sivers + Poet. Back when Sivers did their PR it was "production readiness" https://t.co/EHkOogR39K
I don't think I (or anyone else) can accurately call the bottom. Otherwise they would just do weekly options if they knew. It's hard to see some of the names drop any lower though, like $AAOI is close to 1x annualized fwd revenue/MC. $POET dropped so much that it's roughly ~$800m cash to $1.08B MC. In general, even Leopond finds current valuations extremely attractive, so he's raising more to buy the drop. Who knows though? But medium-long term, for my own thesis, I expect them to play out once revenue projections hit earnings. I've reiterated end of H1 2027 for $AAOI in terms of revenue inflection.... H4 2026 for $NBIS revenue inflection, and so on for my own ests. Of course, lot of volatility in between then.
Lot of people were curious about $SIVE capacity volume ramp modeling through fab-light (Win Semi + others): Using 10% of Win's wafer capacity as a low-end allocation (65% yield assumption, $50-$75 ASP): Sivers would support $341-$512M worth of annual array revenue. Given upper end of managements 50-60%+ gross margin target, would be roughly: $205–307M of annual gross profit. Against Sivers current ~$1.1B MC, would be ~: 3.6–5.4× MC/gross profit if this capacity scenario plays out in 2028. And at 15% would be $307–461M in gross profit (2.4–3.6× MC/gross profit) Sivers CEO also replied that they're working with more fabs for capacity. And from an older deck, there looks to be more qualifications since 2024. So capacity targets might be larger than what's stated here as CPO takes off. I also expect to see revenue pipeline projections hiked in future quarters, as more qualification suppliers to into HVM. _ As for demand side, CW also happens to be very bottlenecked. Lumentum are buying CW off the open market due to EML obligations from their ER transcript. And $AMD are signing LTAs to secure CW capacity (from Trendforce). So when Sivers is ramping with $GFS, $JBL, Ayar, $POET, O-NET and others... Given the current constraints, it's highly likely any independent qualified capacity that comes online would be absorbed. And as a cherry on top, Morgan Stanley named $SIVE (~$1.1B) as one of the three leading CPO laser players . Alongside $55B+ players Coherent and Lumentum in their recent note for a reason... _ TLDR: Sivers only needs a low end allocation from Win to make substantial gross income relative to current valuations. I think the largest revenue upside that isn't modeled in if they TAM expansion with M&A after US NASDAQ listing. By copying the Lumentum playbook with Cloud Light to build out entire transceiver modules or with optical engines.
I don't see any fundamentally wrong. There's probably going to be large corrections from time to time flush out margin/leverage before things move higher. And this month seems like that time of year? $POET confirmed your big optical giants like $LITE, $COHR are completely sold out for the next 2 years, and likely into 2029 for photonics. Innolight confirmed 800g transceiver upward revisions 3 days ago, so that should be positive for $AAOI and the others. Samsung became the most profitable company in the world, and continues to project DRAM hikes for future quarters. $MU signed 16+ LTAs showing memory demand is structural... $META + hyperscaler capex plans are on the higher end of projections. I wouldn't conflate short term price movements with longer term trends. And as seen with $AEHR, recoveries tend to be extremely fast (eg. 1M of corrections wiped out overnight).
For this type of mapping with $SIVE, it's a good idea look at their partners and their timelines. - $JBL confirmed via JPM fireside chat they have a relatively dramatic moat with their 1.6T LRO and are getting qualified done over next 1-4 months (2 months ago). So should be August 2026 to March 2027 timeframes for qual completion, then mass prod start with Sivers in pluggables. - $AEVA are targeting HVM prob q4 2026, $POET is starting off production H2 2026 but probably later in H1 should kick off more. O-Net, Ayar, $GFS and others are somewhere in 2027 I think and that's more along the lines of CPO timelines rather than $SIVE per say. Very confident in terms of execution, since $SIVE has a technical + qualification moat into many different hyperscaler supplier sources. And everyone is incentivized to produce as much as possible, with Sivers as the laser supplier. Not including likely names like $AAPL in 2028. How both the $SIVE CEO and $JBL stated it is: It's more about how much they can make rather than looking at competition (cause demand is so high + different chokepoints are bottlenecked). For me personally, it's just waiting for things to play out. The main area of interest is downstream IP acquisition for TAM expansion, so I think that opportunity pipeline undersells forward growth going forward.
$SIVE is probably my favorite stocks right now, not concerned about short term drops. - You have the laser supplier to $GFS, $JBL, Ayar, $POET, and many other hyperscaler suppliers. - NASDAQ listing planned in the next few quarters - Followed by M&A goals for TAM expansion. And it's literally trading less than $POET for some reason. All while CW lasers are extremely bottlenecked to the point $LITE can't make enough. Then they got a considerable amount of oversubscribed funding for fabless laser ramp recently. Comfortable long for me, probably one of the stocks that way overshot selloff imo.
I personally think $SIVE can be the next $LITE. In the past few months alone, we've seen: 1. Partnerships with O-Net pushing ELS into mass production 2. $JBL 1.6T LRO mass production signals with "relatively dramatic moats" for pluggables using Sivers. 3. $GFS SCALE reference level laser for hyperscalers with pluggable, NPO, CPO. -> -> where $AMD and others went to GFS for CPO. 4. Ayar, which joined $NVDA NVLink for CPO -> -> which removed Lumentum/Macom from their website and likely made Sivers their primary laser supplier. -> -> AlChip likely Trainium win from Amazon price placement (Ayar's customer) -> -> GUC rack level design in with Ayar. -> -> Raised $500m for mass production by AMD, Alchip, Mediatek, and NVIDIA 5. ~ $AEVA starting HVM H2 2026. 6. $POET starting HVM H2 2026 with hyperscaler suppliers like Lumilens ("top 3 hyperscaler initial customer") 7. TFLN + $SIVE CW Lasers with Lightium 8. Likely direct relationships with $MRVL Celestial and CPO players like Lightelligence/Lightmatter. 9. Multiple new undisclosed relationships for pluggables following Jabil in their quarterly transcripts With new Trendforce reports that $AMD and other hyperscalers are trying to source LTAs for CW laser sources, serving as a direct catalyst for independent CW sources. So when hyperscaler suppliers from Jabil to O-Net are incentivized to mass produce as many as they can: That's very material for revenue for Sivers relative to current valuations, and it looks like just a waiting game. Even in the past week: - $SIVE raised an oversubscribed institutional round for volume ramp... This is very nuanced since Sivers is fab-lite so it's not going to in-house foundry capex to scale. Likely toward Win Semi and others (they mentioned other partners too), for laser scaling + foundry allocations. So this is likely signaling material for revenue ramp is coming. - Sivers also mentioned NASDAQ listing completion targeted in the next few quarters (probably H2 2026 or Q1 2027 is my est. timeframe). This would fund M&A efforts, since it's impossible with the fundraising environments in local Swedish markets. As for becoming the next $LITE: M&A makes their lasers more valuable, so downstream IP acqusition -> into contract manufacturing like $FN, and others to make the full 1.6T pluggable or optical engines. Is how they get there, since laser array ASP scaling that people are modeling off of, wouldn't command a $60B+ valuations. There's going to be a lot of bridge architectures like NPO/pluggables, etc and noise around certain architectural delays in the meantime. But markets misunderstand laser companies like $LITE, $SIVE, $AAOI and others are used across different architectures compared to if you just look at certain passive optical components. So markets see "CPO delay headlines" algos sell off laser companies that benefit from other architectures. Being included in the pluggable 1.6T ramp to CPO scale out (Which Sivers is included in), helps bridge revenue waiting gaps until scale up inflection point H2 2027. I'm personally holding long term, since I haven't seen a ~$1.4B company mapping to this many hyperscalers before. TLDR: - Waiting on volume ramps from different architectures to play out across their hyperscaler supplier mapping -> 1.6T LRO/CPO scale out late H2 2026 start into high volume ramp 2027 -> H2 2027 CPO scale up volume ramp - Waiting on NASDAQ listing likely H2 2026/Q1 2027 for M&A efforts to fully take off, unless Sivers get more creative with equity financing in the meantime.
Are you stupid? 1. $JBL mass producing 1.6T LRO is revenue. 2 O-Net mass producing ELS is revenue. 3. $GFS using $SIVE as reference laser for the hyperscalers is revenue. 4. Ayar joining $NVDA NVLink for CPO and using $SIVE for mass production is revenue. 5. Other pluggable players, potentially Eoptolink/Innolight mass producing pluggables with $SIVE as lasers is revenue. 6. $POET entering volume production is revenue.
Nobody should care about TA charts since people just made up squiggly lines trying to convince others to sell. $SIVE just raised an emergency $70M for mass production likely for allocation from fabs. With $JBL, $POET, $AEVA, and others volume ramping near term. Then $GFS, Ayar, and many other players are volume ramping later in 2027. Sivers also confirmed intent to complete NASDAQ Listing in the next few quarters. It's probably my highest conviction photonics long, everything seems to be coming into place.
Photonics is backed by actual revenue numbers and it's an architectural shift championed by $NVDA. Quantum barely has any revenue. $LITE is completely sold out for the next 2 years (per $POET AGM) likely starting into 2029. Lumentum is so strained that they buy CW lasers off competitors (earnings transcript) $COHR is bottlenecked, so they buy EML off Lumentum. Then, $AAOI is coming in with Made-in-America independent CW capacity, are projecting $1.4B/quarterly revenue ending H1 2027 of a stupid $9.3B MC today. So all the CW capacity from independent players who have it now like $AAOI or $SIVE are likely to become scarce resources. Many other hyperscalers have already started LTA discussions (per Trendforce). And players like $AMD are currently talking with players such as $AAOI (Rosenblatt channel checks). Thematically, next 2 years is 9x TAM to US$154B per GS reports, especially with 16x/45x dollar content increase in scale out/scale up. Then there's the overall thematic AI drop from $META, which is widely misunderstood because people conflate what "excess capacity" means. And as UBS mentioned, Meta planning a cloud offering is NOT NEW NEWS. Bloomberg just has a tendency to publish information that causes doom drops across the semi sector like Nvidia export controls a few months back. But I'm familiar with what I'm holding so I'm confident in these numbers playing out. Especially when all the major players are sold out, the fundamentals catch up eventually.
Nah, I actually read the whole $POET AGM transcript in the shower. And then compared what they said, compared to what markets might have known already. This was manual since it’s on some random GitHub page rather than officially published yet afaik. Then I just learn interesting insights from statements like $POET confidently saying laser players are completely sold out next two years. Since it’s signal for laser bottleneck likely extending into 2029 thematically.
Just some notes on $POET AGM and read through on optical markets: - "The top three laser suppliers control 68% of the market, and they’re completely sold out for the next two years" $LITE CEO said into 2028, so POET implicitly confirms laser shortage is going into 2029 now. - NRE with a new customer, building on POET’s interposer for high-power external light source. This is high confidence $SIVE as laser supplier given the Sept 29, 2025 PR on ELS, and new customer qualification would be material for revenue if it goes into volume ramp. - Poet expects Lumilens commercial agreement to scale to over $500 million over the next 5 years. Lumilens claimed a top-3 hyperscaler was their initial customer (Linkedin OSINT) - $830M cash on hand on balance sheet (this is more for Poet fundamentals). - "The entire optical components industry today is facing a severe shortage of critical components." Reaffirming what we know already regarding optical bottlenecks. - "Production ramp in the second half of 2026 this year." Just production timelines H2. In terms of $POET volumes: - existing capacity around 1 million optical engines per year - projected demand exiting 2027 around 1 million optical engines per month - roughly 10x capacity expansion I don't own Poet, but if management delivers on these projections it directionally looks very positive. However something to note is that unlike other suppliers that have named hyperscaler customers to to back up capacity revenues like $AAOI: $POET seems more questionable. But this does look like a very positive outlook for $POET if they match projections.
$SPCX / Elon Musk acquires Mesh, an optical networking startup. Which is working on 1.6T OSFP (pluggable). It’s seems they own the optical engine/packaging side of things, but likely sources CW DFB lasers off merchant companies. $SIVE is one of the more startup friendly plausible merchant suppliers as seen with Ayar to $POET? Maybe $LITE and $MTSI that were have a little history too, but less so. Regardless it’s very positive a lot of startups recently like Celestial have been acquired by Marvell. For both merchant laser supplier revenue (working with startups -> having hyperscalers like SpaceX drive revenue after being designed in already). As well as valuations from M&A desirability. Goes to show how optical interconnects is the right direction if Elon Musk is directly buying these companies.
Not really, I personally still think it's undervalued. It's about MC relative to forward revenue potential. In just that tiny timeframe for $SIVE: - $JBL announced 1.6T LRO with Sivers - $GFS reference laser announcement with $SIVE - $AMD went to $GFS for CPO - $SIVE announced CW with TFLN - Ayar (using $SIVE) raised a bunch for volume ramp and joined $NVDA NVLink ecosystem - AlChip private placement with Amazon, which is Ayar's primary ASIC partner (hinting at Trainium wins) - O-Net new ELS partnership with $SIVE for mass production - $POET new purchase order with a customer that stated their initial clients is a "top-3 hyperscaper" - New CHIPS Act nondilutive funding - "LIDAR customer will ramp production starting Q4 2026," which is likely $AEVA - New information discovery likely linking $SIVE customer to $MRVL Celestial (not through Poet), Lightelligence, and Lightelligence. - New information discovery about Ayar removing Lumentum / Macom from website and likely making Sivers primary source - More pluggable players on top of $JBL. - $NVDA bottlenecking CW laser supply and $AMD + other CSPs going around signing LTAs - NASDAQ listing planned And more.
oh i think u misunderstand... I'm actually more bullish than ever as prices go down. $SIVE at ~$1.9B MC you have: - $GFS reference laser - laser for Ayar and others in $NVDA NVLink ecosystem for CPO scale up - $POET and others for CPO scale out - $JBL and others for 1.6T+ pluggable optical transcivers - O-Net for ELS mass production So you have all these hyperscaler suppliers trying to create as much as possible with Sivers as the laser bottleneck... And it's just a matter of how much Win Semi + others partners can make, with $SIVE receiving ~60% gross margins + optionality to TAM expand downward. The 15% recent share expansion that Swedish media have been bearposting is for NASDAQ listing float + M&A (and it's authorization). You just have potential short sellers running illegal bot farms, Swedish media bearposting a company Swedish exchange, on top of a general macro drop. The ~$140M convertible note is real, but it's pennies to US institutions. We'll likely see more institutional ownership when data comes out. But this is also why it's good for $SIVE to prioritize NASDAQ listing so they don't need to deal with this noise and local media. With $AAOI at $10B, you have: - A end-to-end US laser/design/assembly player projecting $471m month revenue H1 entering H2 2027. - With other hyperscalers like $AMD apparently discussing LTAs. And they probably are sitting on a ton of cash after running ~$1.4B in ATMs (400M + 400m+ 600m). Kinda all that needs to be said with those insane revenue projections as long as management doesn't BS. This just reminds me of when $NBIS crashed to $70 last year even while projecting $7-9B ARR, and as timelines got closer it recovered to $250+. Feels like dejavu. I'm just waiting for both volume ramps to hit. Photonics are generally more volatile than the rest.
@RJCcapital Bruh $SIVE is $GFS reference laser, $JBL 1.6T pluggable laser, Ayar CPO scale up laser, $POET scale out laser, O-Net ELS laser. And many other undisclosed partnerships. Watch and learn.
@Web3Eden01 Short sellers (eg. Night Market) were claiming Lumilens had no customers on their $POET short report. So Lumilens going out and saying they have a top-3 hyperscaler customer is probably pretty material.
Fun new information discovery from Poet OSINT community: Seems likely that $POET / $SIVE are going to power a Top-3 hyperscaler (either Amazon, Microsoft, Google). Given a Linkedin update from Ankur Singla (CEO of Lumilens). Who stated their customer is one of the top 3 hyperscalers with their post focusing on CPO/NPO. With that clue, seems more likely the Sivers CW DFB light source path over other EML suppliers given it's CPO Scale Out/NPO. If you don't remember, Sivers is the laser supplier to Poet. And Poet has purchase agreements with Lumilens. Always fun to find major potential breadcrumbs in the wild before they're officially confirmed. (Disclosure, long Sive)
Mapping like - JP Morgan fireside conference for Jabil timelines + Quotes around 1.6T LRO - Sivers 2025 annual around $POET various press releases with $GFS and others. - Old investor customers decks mapped with different investment rounds of cpo startups at the time All merged together into a thesis.
That’s a misconception: $SIVE is the laser supplier for next gen architectures, not just CPO scale up. Pluggable, scale out CPO, scale up CPO, NPO, etc. - Sivers and $JBL went god-mode and developed 1.6T optical transceivers with CW lasers. Effectively designing around the EML bottlenecks, and even made things more power efficient. From quotes from Jabil management they created a “relatively dramatic moat”. So for the next gen of 1.6T pluggable transceivers, Sivers seems immediately used. Markets missed this nuance too: after Jabil’s announcement, other pluggable players reached out, and SIVE is working with them now (prob codevelopment, qualification stage). There’s not too many players that build optical transceivers that aren’t vertically integrated like Lumentum (think: Innolight/eoptolink, and maybe others). So these are active developments, just not public material yet and could be a new press release anytime. - for CPO scale out which happens H2 2026 onward like $POET, $SIVE is a laser supplier for those players. - scale up CPO is h2 2027, from Ayar and Nvidia’a NVLink CPO ecosystem and that’s the main volume ramp across optical players. But this is where $SIVE looks like they mog every other player from supply chain mapping. Since they’ve likely been working + designed in with $MRVL Celestial, Lightmatter, Lightelligence and the others since they were small way back when. On top of things like this: For foundries like $GFS, $SIVE is the reference laser. Not even including massive companies like O-Net building ELS with $SIVE, likely for the Asian hyperscalers supply chains. This is why $SIVE is by far my favorite laser chokepoint long. Feels like they’re everywhere in new optical architectures starting beginning of 2027.
Yes, choosing the right theme is extremely important. Even if $POET doesn't really do anything, it still gets brought up thematically due to $LITE, $COHR, and others. Even if $RDDT outperforms extremely hard, it still gets brought down from $META, $MSFT, $CRM, and other software basket names.
$SIVE is the next SIVE. Don’t think you’ll find another company. That’s qualified and likely primary/sole source with: - $JBL and other pluggable hyperscaler suppliers - Ayar and the $NVDA NVLink CPO ecosystems While being the foundational reference laser for $GFS and pluggable/CPO/NPO deployments. That hyperscalers like $AMD and others use, at current valuations. Even $POET buys $SIVE lasers and Poet is about the same valuation just off having one $50m purchase agreement. Amount of hyperscaler suppliers for 2027 into 2028 is just ridiculous. From the general meeting today in a few hours, we’ll hopefully see NASDAQ listing timelines confirmed. So they can have room for M&A to TAM expansion and to make each laser they sell more valuable. Following what $LITE did to grow into a $75B company.
@chenchuwei85698 $POET is sitting on too much after another $400m private placement. So they're near ~$1B pure cash. Not a fan of poet, but even if their tech doesn't get qualified into hyperscalers, they can always acquire other companies to scale.
Many work against the interest of retail investors. Especially as JP Morgan / US institutions are trying to buy up the float. You have a company funded with CHIPS Act, in major hyperscaler supply chains from $NVDA to others, powering Ayar for CPO, $JBL for pluggables. And now the reference laser for $GFS. With closest ramp with $AEVA / $POET likely coming next. And following that likely US NASDAQ Listing. Sivers is one of the most compelling photonics companies, and pretty sure all the deals established that already.
Okay chat, here's your compiled list chat of your favorite 800V DC related ideas. 1. $IFNNY - $115.8B 2. $ON - $46.2B 3. Lite-On (2301) - $16.03B 4. 6504.T - $14.1B 5. $VICR - $12.8B 6. $LFUS - $11.57B 7. https://t.co/1unM4FPf65 - $8.34B 8. $VSH - $7.86B 9. $ENPH - $7.36B 10. $NVTS - $5.77B 11. $POWI - $4.30B 12. $BDC - $4.18B 13. $EOSE - $3.86B 14. $SEDG - $3.82B 15. $AEHR - $3.1B 16. 6890.T - $2.66B 17. $WOLF - $2.16B 18. $CWR.L - $1.75B 19. $AMSC - $1.68B 20. https://t.co/43OXU9tx65 - $1.68B 21. $XFAB - $1.54B 22. $AOSL - $1.25B 23. $HYLN - $1.23B 24. $FCEL - $835M 25. $IQE.L - $780M 26. $ASYS - $276M 27. $RELL - $239M 28. 6844.T - $222M 29. 4973.T - $207M 30. $PAY.BR - $189M 31. 6616.T - $186M 32. 6882.T - $124M 33. $IPWR - $96m Also included some adjacent ones you all mentioned like $FCEL or $EOSE anyway, tho idk it's great exposure. Ignored the clearer irrelevant stuff like $POET that people mentioned tho. There's like 500 comments, but I guess X limits everything I can see. We'll see how your highest conviction ideas do.
The difference between NASDAQ and EU listing: $POET: $2.4B MC -> Packages Sivers lasers -> One $50m pre-production contract for warrants > $XFAB: $1.7B MC ->SiC/GaN/MEMS/Silicon Photonics Foundry backed with EU CHIPS ACT, US CHIPS ACT PMT -> Below replacement P/B value -> $NVDA, $NOK direct eval of their pre-commercial SiPH foundry, volume ramping 2027/2028 -> $XFAB leading high-volume scaling of Europe's photonic supply chains as the foundry, with IMEC/CEA-Leti, Ligentec, Smart photonics, PHIX Photonics, Luceda Photonics, and Europe's photonic players under it. -> Leading customers like $NVTS, $POWI, Lite-On -> US from Dpt. of Commerce: "the only high-volume SiC foundry in the U.S."
-> IP acquisition -> Just waiting for CPO to take off $SIVE is a laser chokepoint for photonics and are publicly validated by: - $GFS (1 of 2 public laser suppliers with $LITE for CPO per presentation) - $JBL (“Relatively dramatic moat” for pluggables built with Sivers) - CHIPS ACT for the overall company For highest visibility: -> Ayar is the largest CPO player that primary sources $SIVE and are expected to ramp in 2027. -> $POET is another near term CPO volume player that’s heavily visible with Sivers. For OSINT mapping: $MRVL Celestial (direct, not through Poet), Lightmatter, Lightelligence, were all high confidence customers of Sivers. $SIVE is also developing/qualifying with multiple more optical transceiver players following Jabil. It feels like they’re going to end up everywhere. I’m not sure people realize how special that many qualifications is coming from a <$2B MC laser company is… right before 2027 volume ramp. Especially while all the other laser companies trade at $15B-$70B valuations. Just need pluggables to bridge revenue gap into H2 2027 (CPO Scale up) Then making every laser they sell more valuable following the $LITE playbook, to capture more TAM of both markets. - In the overarching optical $141B TAM (10x) in the next 1 1/2 years. (Goldman Sachs) - and CPO TAM going from 0 to $81B in the next 1 1/2 years. So, easily multiply revenue opportunity overnight doing IP acquisition downstream. It’s more of just a waiting game, I think $SIVE is very undervalued relative to forward revenue potential. If it were a private Silicon Valley startup it would probably be worth $4-6B today. Just needs to get listed on NASDAQ for premiums to bridge that gap.
There's a new $SIVE short seller with 0 clue what they're talking about. 1. $MRVL Celestial is likely buying lasers directly with $SIVE as the laser supplier, not through $POET. As they've been identified as a likely direct customer since 2023. An analogy is if O-Net / Enablence / Sivers, and O-Net worked directly with $SIVE (which they have) but vertically integrated away Enablence. They're still likely buying $SIVE lasers. 2. $SIVE is clearly the likely $AAPL supplier for lasers. I use the term likely, because although markets are 99% sure, the BOM is confidential. The short seller is claiming it's TASC, which I've already identified multiple times as an Apple supplier. But falsely they're conflating two different generations of Apple Watches with photodiodes and lasers for glucose monitoring to say $SIVE is not a supplier. 3. US NASDAQ listing is likely incoming soon after the new board meeting and shareholder vote. Upgrading accounting standards and having immaterial changes doesn't mean anything. 4. Ayar labs hasn't scaled up yet. Ayar specifically listed $SIVE as their primary laser supplier in their website. With their executives going out on statement that they couldn't built their products without $SIVE lasers. Claiming $SIVE isn't shipping volume to Ayar when their CPO products haven't ramped is stupid. 5. There's zero leak around news for listing. Hilarious coincidence and management has always been pursuing NASDAQ listing since last year. Short sellers keep repeating this disinformation to try and profit. 6. I've never seen such hilarious BS around Win Semi volume scaling. High confidence in SpaceX and $AVGO supply chain critical foundry. 7. Using arguments from authority saying they know an engineer and then having them confusing architectural differences between $LITE / $COHR and $SIVE is hilarious. Regardless -distorting financial statements -conflating different gen architectures and timeline NRE - reiterating false accusations to profit off short term sentiment is likely going to see them turn into a long as CPO/Jabil partnerships volume ramp.
$SIVE is the most compelling CPO/photonics exposure to me. Addressing the disinformation: I haven’t sold and don’t plan to sell a single share. I do think this ends up the next $80B+ $LITE one day from ~$2.1B. And I personally have plans to acquire more ownership + support their M&A prospects. I believe earnings transcripts will be strongly positive. As in the part few months we’ve discovered: > AlChip/Amazon private placements, which is positive for Ayar -> $SIVE implying Trainium 4 design in > Wiwynn + Ayar CPO scale up > $JBL 1.6T optical transceiver ramp with Sivers incoming faster than markets expected (with relatively dramatic moat + demand as much as they can produce) > O-Net scaling up ELS efforts with $SIVE > $YSS acquisition of $SIVE allspace lead partner, designing Sivers into Space defense primes > New CHIPS ACT funding for $SIVE > $POET H2 volume ramp and their new $50m -> $500m order (with $SIVE as light source) > information discovery around $AAPL using $SIVE lasers for next gen consumer devices > information discovery around links to Lightelligence (went public $10B+ MC) + Lightmatter as likely customers. > Celestial volume ramp with $MRVL indicators. > new customers working on TFLN with $SIVE like Lightium > $AMD going with $GFS for CPO, and GFS listing sivers as one of two laser suppliers > Ayar removing $MTSI / $LITE from their website and signaling $SIVE as primary source/sole source > Ayar raising $500m for volume ramp (intel, Mediatek, Nvidia, amd etc) > pluggable TAM expansion signaled from 2025 annual report > Nasdaq listing expected soon > MSCI small cap index / Nasdaq omx inclusion, making Blackrock, Vanguard and others passive buyers > M&A signaled from 2025 annual report + 2 new board members that have experience in that area > $NOK as likely customer from 2025 annual report. > $LITE getting cw bottlenecked from EML contracts, $SIVE signaling capacity agreements in place with Win, making the a likely bottleneck owner + chokepoint in CPO sector. All of this market research was done before earnings. Any results is just confirmation of supply chain mapping done. I don’t think anyone cares about former quarter revenue since $SIVE is an exceptionally compelling 2027 long, especially H2 onward. Only thing I’m looking at are: > TAM expansion of the overall photonics supercycle (eg. optical engine, ELS, pluggables) either from M&A or developments > volume ramp expectations from existing companies > Nasdaq listing timelines for more liquidity to support their M&A efforts > any new customers signaled for CPO/Pluggables
$MRVL earnings were a bullish indicator on the broader CPO theme (and $SIVE as the likely laser supplier). - “Scale-up interconnect represents one of the newest and most strategically important opportunities emerging in AI infrastructure.” CPO thematically go brrr - Confirmation Celestial was selected by T1 hyperscaler for scale up. I’ve found Celestial $AMZN warrants in the past)… so probably Amazon. - Scale-up optics revenue next year should be more than 2x prior ~$150M outlook with Celestial Forward revenue ramp expectations go brrr. - Celestial team plus $MRVL optics team was a “home run”. Marvell sees celestial as growth vector, upstream celestial suppliers go brr - $MRVL is now focused on bringing Celestial to high volume manufacturing. Volume ramp indicator If you don’t recall, there was OSINT mapping $SIVE directly to Celestial, not through $POET. So Celestial forward growth is a volume ramp indicator for Sivers lasers.
@Mengmengeth Well $JBL is new TAM expansion into pluggable optical transceivers. CPO with Ayar, $POET, Lightelligence, Celestial, and those players are entirely new. So having both helps $SIVE bridge the valuation gap faster.
$JBL literally announced in their fireside chat… Mass production of their 1.6T LRO with excessive demand in 3-10 months. $SIVE is likely sole source laser supplier for this specific optical transceiver. Ayar raised $500M for volume ramp recently, and $SIVE is the primary / sole source laser supplier. 2025 annual report, $SIVE signaled start of volume ramp with both (likely) $AEVA and $POET. This is how you do supply chain mapping on qualification cycles. Anything they make, Sivers makes revenue off lasers. If you ask AI they will keep confidently citing 2024 revenue numbers without knowing volume hints. Which is why I keep seeing these false claims like this over and over, despite Sivers being on the precipice of mass production for 2027.
Nah, I think $SIVE is still extremely undervalued relatively speaking. Ayar, Lightmatter, Lightelligence, celestial, and others all probably command $5-$15B+ valuations. Not even including small guys like $POET or pluggables like $JBL. Sivers lasers likely power them all, and they’re primary/sole source for a lot.
When I do my supply chain mapping... $SIVE is just so critically important to so many frontier industries. I'm not sure people are fully aware yet. $SIVE -> $AAPL, $NOK, $RTX (us defense contractrs), $YSS (golden dome). Not including Ericcson + others. Then you have $SIVE -> $AEVA -> Boston Dynamics / $NVDA self-driving architectural standards. Then you have $SIVE -> Celestial / $POET / Lightmatter / Lightelligence / Ayar / $JBL, and many others for CPO/1.6T. Those go to GUC/ALCHIP/Marvell -> hyperscalers. Then there's a ton more... Like their US Gov CHIPS Act work that are secretive. Normally with stuff like $POET, it's like "hey" you have 1 customer with a $50m purchase order, we know where that's going. Not some Swedish company with a smaller valuation, going into everywhere from Space, Robotics, AI, consumer segments...
For $SIVE to become the next $80B+ $LITE. Sivers is the current laser kingmaker of the optical transition to CPO and 1.6T. They basically supply lasers to the leading players in the CPO space. From likely $MRVL Celestial, Lightmatter, Lightelligence, $POET, and others for CPO. before they got big. And now with large players like $JBL for 1.6T LRO + more test/qualifications underway for pluggables. They've finally solved the Catch22 problem, and have the attention of the market to pull off foundational CPO related IP acquisitions downstream on NASDAQ listing (or now with equity). And expand revenue as much as possible from the laser source into: -> Optical Engine/ELS value. -> Optical Transceiver IP Just like $LITE did to drive their valuations from $2B -> $80B in 2 years. But instead of EML + pluggables, Sivers is doing this for the CPO supercycle, the fastest TAM expansion in history for photonics. I'm following the story for them to pull this off this David vs. Goliath shift catching up to $LITE. More than I care about little MC % returns that's happening currently.
Just putting it out there: $SIVE short interest is probably higher than 17%+ now. As lot of local Swedish hedge funds are very underwater, shorting Sivers. They're about to meet US institutions through: > MSCI inflow in 2 weeks. > NASDAQ Listing. > US CHIPS Act backstop. alongside core revenue driver from the optical supercycle revenue ramp from likely $AAPL, $JBL, $POET, Ayar, Onet/Enablence, Lightium, $AEVA, $MRVL, Lightmatter, Lightelligence, and $AMD over the next year or two. I personally don't think it's going to end well for the Swedish locals shorting (and some random algos) at this early stage. And the popular saying is every one stock short turns into a long eventually.
$POET and $IREN literally both won the Fake it Until you make it award. -> Grey area endless marketing of crap through influencers. -> Diluted retail enough to hoard tons of cash -> Cash is sets baseline Market Cap. Now $POET probably has around $830M pure cash from dilution after $400m private placement. While their marketcap was sitting under $500m last year.
When I see comments like this (and there are a lot) from retail investors: I immediately think they lack the technical depth. I'll walk through each one from $SIVE to $LPK: 1. Photonics TAM goes from $14B -> $154B In just two years time, and it's likely going to keep scaling past 2030 as it's the next generation architecture of choice. It's not going away in 1 year. It's not going away in 3 years, which is why $LITE premiums keep going higher since they're backlogged into 2028. $SIVE supplies CW lasers and is highly tethered to CPO and now pluggable transcivers for 1.6T and 3.2... For expected companies like $JBL, Ayar, Lightmatter, Lightelligence, $POET, $MRVL Celestial, and $AMD. This isn't a "trade", it's the core chokepoint and IP holder for the next generation of photonics. And it's a comfortable hold for the next few years as they scale to become the next $LITE. The risk I personally see (since they're already qualified with so many players), it's mainly how much TAM they can capture of the overall optical supercycle. (And potential risks with Win Semi volume ramp, but Win is massive so I can sleep tightly there). As just supplying lasers isn't enough to justify valuation. It's TAM expansion downward into making the entire ELS or entire pluggable transceiver that makes these laser companies so valuable. Then afterward, they can vertically integrating upward for gross margin expansion upward like $COHR into doing the laser fabs or even substrate level. And that in my view is a very asymmetric risk/reward ratio as we've already seen this done with $LITE as they went from $2B to $80B. 2. $LPK - Is the purest exposure, without the messy financials of SKC Absolics, as the next advanced packaging shift for glass substrates. Almost every single major semi company from $INTC to Samsung are adopting glass substrates. $LPK is basically $ASML of this chokepoint, since they supply to ~80% of the global players currently. Yes, there's "trade cycles" for equipment suppliers like $ASML, where if there's more foundry capex, ASML scales up. But if there's downturns, these tend to perform poorly, and don't capture all the volume ramp that happens after. However, if the MC is $650m and they're making $100-200M, revenue per costumer volume ramped, the amount they make from the glass substrate cycle will likely exceed current valuations. And they'll have baseline fundamentals (as more companies adopt the packaging shift), that keeps their valuation up. It's just a waiting game for volume ramp at this point. 3. $AAOI - This is literally $INTC but for America + Photonics. It's like saying Intel is not a long term investment. Guess where all your optical transcivers are made? China. Thailand. Malaysia. If you look at Innolight, Eoptolink, $FN, and others. AOI is building the largest Made in America supply chains for both CW laser fab, as well as 800g, 1.6T assembly. Yes, there are pluggable cycle ups and downs to this as well. There's going to be a wave for 1.6T next year, then CPO cannibalizes pluggables down the road. But since they make the entire supply chain in house, they have extreme optionality for other segments. And like $NVDA older gen-GPUs, there's going to be sovereign DC requirements for older gen pluggables from names like $AAOI. It's likely going to keep rising as it hits that $400m+/month revenue target H2 2026. There's just a lot of different short term volatility along the way like the $600m dilution. 4. $IQE - ??? It's one of the most important players in the Western word for epiwafers. $MTSI went out of their way to pay off IQE's debt because they can't have them going under. $IQE is also supplying to $LITE. The world is currently bottlenecked both on the epiwafer level from Landmark comments and InP substrate levels. Their financials were track but the raw book value, and value they hold to the entire Western supply chain... completely justifies their valuation. And other optical companies will not let their core upstream supply chain go under. As these tens of millions worth of materials would screw up tens of billions worth of downstream products. Again photonics is the next generation architecture required to scale AI. It's not Quantum where it's just "In development". It's literally here and the architecture of choice by $NVDA. I would not be surprised if all of these are a lot higher in 3-4 years time. People who think it's one and done in 3 months time "only because I mentioned it" don't know what they're talking about. Institutions would have bought up the name eventually (like Point 72 on $IQE) and retail would only find out after their valuations are 600% higher. Should really do the research before adding comments like these: These are all forward growth companies that require in-depth supply chain knowledge.
HOW DOES $POET ($3.14B) HAVE A HIGHER VALUATION THAN FOCI (3363, $3.1B)??? FOCI IS LITERALLY THE BOTTLENECK FOR CPO VOLUME RAMP AND MAIN SUPPLIER FOR $TSM AND $NVDA. High conviction Foci outperforms once institutions find this name. Also, can Foci management please pursue NASDAQ ADR like $HIMX? Thank you.
If you didn't know $POET is up 22% premarket on a $50m purchase from Lumilens. Scaling to $500m with a longer term framework. As mentioned in Sivers 2025 annual report: $POET is ramping up H2 2026 with $SIVE. Any demand from these midstream players back to $SIVE as the laser chokepoint for everything. So yes, this is highly bullish for Sivers.
$SIVE 2025 annual report analysis. TLDR: Extremely Bullish. Sivers main growth vector is CPO, but they've TAM expansioned to pluggable transcivers + multiple new qualifications/development. 1. "We are currently seeing great interest... testing our DFB lasers across multiple manufacturers in pluggable transceivers" For pluggable angle, we've seen this with $JBL 1.6T LRO already, but annual report hinted they're developing/qualifying with more hyperscaler suppliers. "Our serviceable markets have now been expanded to include pluggable optical interconnects as well as scale-up and scale-out architectures for co-packaged" (TAM expansion) 2. "Discussions with hyperscalers and pluggable transceiver suppliers indicate a shortage of CW lasers in the coming years" $LITE already signaled CW laser bottlenecks, and they had to buy externally from competitors. So we kinda guessed CW Laser was a bottleneck. And this confirmed it, so was wondering about Win semi. "The partnership announced with high-volume supplier Win Semiconductor in March 2025 now gives us a strong position to meet growing demand" $SIVE likely has capacity locked in with Win from this nuance, which is exactly what I wanted to know. This positions Sivers in the CW laser as both a bottleneck and CPO laser architectural leader. VOLUME PRODUCTION H2 INDICATIONS (BULLISH): 3. "The collaboration positions both companies to address the rapidly growing market for optical AI connectivity, with prototypes to be demonstrated to customers during the first half of 2026 and with the goal of scaling up production by the end of 2026" H1 is more preproduction, H2 production signaled starting with names like $POET. 4. "We are pleased that our largest LIDAR customer will increase production starting in the fourth quarter of 2026" $AEVA start of volume production Q4 with $SIVE = bullish for both. Revenue floor from LIDAR as their CPO scales. 5. Sivers announced a partnership with LIGHTIUM AG to integrate their CW lasers directly onto TFLN wafers. 3.2T+ cycle. (future proofing) FYI no decent investor cares about last year's 2025 financials from development contracts aside from Swedish Media/Locals. Especially when you're forward looking for the 2027-2028 CPO supercycle. But the hint from you can take away from financials + geography that is $NOK is now the high confidence customer of $SIVE. TLDR: -> Win Semi implied capacity lock in during CW laser bottleneck -> Hints of new group of hyperscaler suppliers testing/qualification for pluggable transcivers, which is massive TAM expansion. -> New customers for CW lasers -> Volume production scaling starting H2 for both photonics and lidar.
Uh, was there any news with $POET … Or does the universe just not like short sellers? https://t.co/8rYaWornYf
Just a recap of recent information discovery + likely mapping with $SIVE: -> $JBL 1.6T -> Lightmatter -> Ayar -> $MRVL Celestial -> Lightelligence -> $POET -> $GFS ecosystem -> $AMD CPO -> O-Net / Enablence -> $AAPL Silicon Photonics _ -> $YSS Golden Dome/DoD -> $RTX / $ERIC (Space) -> Bae Systems -> $AEVA With $JBL to Ayar feeding into hyperscalers like $MSFT, $GOOGL, $AMZN, $META. With likely Lightelligence to O-Net feeding into Asian Hyperscalers like Tencent, Bytedance, and Baidu. On top of that... the overarching TAM with CPO from the GS report goes from 0 -> $91B. And Sivers happens to be the bleeding edge for CPO (also starting from 0). This is definitely high-beta and volatile. But if Win volume ramps alongside $SIVE, I see them both becoming $10B+ companies next year. This is just extremely early on (H1) before the CPO supercycle starts H2 2026.
It's pretty insane to see $SIVE become a Tier 1 laser supplier for CPO. This is my prediction/guess with est. mapping: $NVDA ate up all the capacity with $COHR, $LITE after their new $2B+ spending spree. Same playbook with EML early 2025, causing the bottleneck seen today. Now, $AMD / hyperscalers are scambling for upstream laser suppliers. Hence why $SIVE + Win / $GFS became likely primary route to go down. You can see this with: -> $MVL CPO through Celestial (Nvidia signed a deal, but they don't have lasers) -> $AMD CPO -> Ayar -> $POET -> Lightmatter -> and other programs (eg. Jabil 1.6T) As a result, Sivers/Win emerged as the Tier 1 bleeding edge + critical independent laser supplier. And there's hints for this when: 1. $GFS listed $SIVE / $LITE as the two only public laser suppliers in their ecosystem. 2. Ayar removed $LITE / $MTSI off their website and elevated $SIVE to their primary laser supplier. So everyone else ended up going with Sivers since $COHR / $LITE are fully allocated. My guess is that a lot of the secondary suppliers also capture overflow as architectures standardize. But scramble for this chokepoint will be insane early next year given $NVDA bottleneck. And a small $1.2B Swedish company in $SIVE will be in the center of it.
As for 3x brrrs these levels: 1. $SIVE 2. MSSCORP (6830) 3. Auros (322310) Are my best guesses. Here's my thought process: 1. $SIVE: I genuinely do see them being $10B+ next year, they're the literal bleeding edge for CPO lasers alongside $LITE and $COHR. At a $1.3B MC... For likely mapping: Photonics: $AMD CPO, $MRVL Celestial CPO, $JBL 1.6T, Lightmatter, Ayar, ALChip, GUC, O-Net (ELS), $POET. For Space + Defense: Golden Dome via $YSS, $RTX / $ERIC / Bae Systems. Silicon Photonics: $AAPL (Apple Watches). This is just a stupid amount of customers and it's still increasing. They can always TAM expansion downstream through IP acquisitions or vertically integrate to speedrun $LITE's $60B MC one day once they get more funding. 2. MSSCORP (6830): CPO monopoly over inspection at ~$1.2B. 100% monopoly over CPO yields, $TSM, $AMAT, $NVDA, $LCRX, $INTC, and others are all likely customers. "The company’s goal is to seize a 90 percent share of the CPO inspection market" This basically means 100%, they just don't want antitrust. If they defend their monopoly and CPO ramps, can easily see this worth ~$5B-$9B from $1.2B 3. Auros (322310): Samsung / SK Hynix supplier at ~$210M for Hybrid Bonding Metrology. Basically pure play on two products: -> HBM4 / HBM4e / HBM5 cycles, that $KLA had a monoply over for IR metrology. ---> Getting qualified now likely in Samsung factories, H2 volume ramp est. Sk Hynix likely qualifying too when they upgrade to hybrid bonding. -> Thin-film thickness measurement. ---> Getting qualified now, with "major domestic chipmaker" (either Samsung/Sk hynix), targets mass supply this year. They've been developing for the past decade, only to volume ramp two products from years of qualification H2 this year. Seems extremely likely to 3x to $630M if they switch to volume ramp, feels like an undiscovered gem in the Korean market? Of course, not sure how they play out and this is all speculative but high confidence supply chain mapping. But off the top of my head these three that I own are the most likely ones at this level.
So $POET does the packaging side of things. If $MRVL dropped Poet, it means Marvell felt they could vertically integrate that layer into Celestial and just buy lasers directly themselves (not just the nda dispute). Marvell would still need to buy lasers. I'm sure they're planning multi-source contracts but I don't think $NVDA would share allocation to $MRVL. Which is why $SIVE is likely still the laser supplier direct to Marvell since they fit celestial specs already, and that just cuts out a middleware player.
Pretend $SIVE, $LITE make specialized blue and red maine lobsters. Very rare, not many people can do. $POET steams the lobsters and prepares it in a ready-to-go container. $MRVL buys those lobster tails, puts it together on a plate with broccoli and steak. Then serves it at the highest price to high end customers. Marvell is famous for serving Blue lobster tails. But can always serve Red ones, and it’s easier to keep serving Blue that they’re used to. And it’s also possible for the Red lobster farmer to shift to Blue lobsters with some effort, but it takes time to raise those lobsters. But… it just so happens Marvell’s competitor Nvidia bought out all the Red Lobsters for their restaurant. In the end, they still need those rare blue Maine lobsters. But just decided to steam it themselves. That’s $POET and $MRVL situation. It’s likely they’ll just go buy lobsters directly since you can’t just spawn Blue lobsters.
I've always maintained $POET can get designed out and likely would in a few years for $MRVL. Especially as hyperscalers tend to vertically integrate upstream, I just didn't expect it so soon. For me to be bullish, $POET would have needed to multi-source to multiple hyperscaler supply chains rather than just Marvell. However, this goes this show: There's a reason why all the Laser companies are worth tens of billions. Laser design and fab is much more difficult than companies like $POET buying the lasers to package them. If $MRVL were completely reliant on $POET, they wouldn't break off the engagement despite the NDA, so it does feel like an excuse. Poet was just the fastest time to market given it's already designed into Celestial, but serves more as a Gen-1 bridge. Regardless all the hyperscalers require a light source (which is much much more difficult to vertically integrate): And after $NVDA went and bought out allocation for $LITE, $COHR... There's not many laser suppliers left aside from $SIVE. There's a lot of nuances markets might miss, but packaging layers are different than laser layers. It's highly likely now $MRVL just buys lasers directly from Sivers (which is even more bullish) given they already match Celestial specifications. And also highly likely Marvell multi-sources with $MTSI and $LITE (if there's any capacity left).
$MRVL cancelled $POET purchase orders after the CFO went out and violated NDA when getting angry. Ouch to Poet, down -46%, this is why I don’t like companies with single customer concentration risk. On the bright side for $POET holders they do have $420m cash buffering downside risk and a few other customers (though Marvell was basically the entire Poet bull case story) It does look like Marvell delayed their own timelines as well by doing this. That being said, the packaging side is easier to design out for Marvell and they still need to source lasers.
TLDR of recent news + bottlenecks that go brr: 1. CPU bottleneck - $INTC CEO said AI inference pushed CPU Ratio From 1:8 to 1:1. CPUs go brr ( $AMD, Intel, $ARM) -> $AMAT / $TSM / $KLAC, etc. go brr. 2. PGME / PGMEA shortage. DuPont, Shiny Chemical, Daxin, San Fu, $DOW and others go brr? Photoresist bottleneck go brr? 3. Microcontroller potential bottleneck + price hikes (Arterytek/Arterychip) was weighing price hikes on AI capacity squeezes. MCU companies potentially go brr? 4. President invoked the "Defense Production Act" this week, it included: -Transformers - transmission components - advanced conductors - power electronics - substations - high-voltage circuit breakers - protective relays, capacitor banks - electrical core steel As "severe shortages". Stuff like $AMSC, $PLPC, $POWL, $VICR, $ATKR, $HPS.A go brr. 5. $GOOGL ramps new TPU servers. Google splits AI chips into training and inference TPUs. Taiwan happy. Mediatek and others go brr? 6. Samsung, Kingston lift SSD prices by over 10%. SSD prices keep going brrr? 7. T-glass fiberglass shortages keep getting worse? Nittobo and others keep going brrr? 8. Bromine, essential for etching circuits and flame retardancy, has surged to $12,000 per metric ton. ICL Group in Israel apparently controls 40% of the global supply? Not as familiar with this but questionable brrr? 9. "Epitaxy manufacturer LandMark Optoelectronics reporting output still far below customer needs". Uhh $IQE and others go brr? 10. "AI data centers hit interconnect limits, boosting optical module demand". "the bottleneck is no longer computing power alone, but how that power is connected." Photonics from $AAOI, $LITE, $COHR, Innolight and others keep going brr? next gen from $SIVE, $POET, $MRVL, Win Semi and others go brr? Basically AI semi supply chains go brr because there's widespread shortages everywhere due to AI hyperscaler demand.
Agreed, and glad DNB, one of Europe's leading banks, went out to defend $SIVE valuations alongside me. I still think $SIVE can reach $10B MC in 1 year time as their laser growth scales proportionally to: - $AAPL Watches - $JBL 1.6T Volume - $MRVL CPO Volume - Ayar Volume - $POET Volume Depending on how their qualification plays out into volume ramp. As Sivers supply lasers to all the next generation of 1.6T/CPO players in the space (into ~ $AMD, $NVDA, $AMZN, $MSFT type supply chains). These are EXISTING players at a ~990M MC. Not even including TAM expansion or more partnerships coming up. Especially now with NASDAQ listing, US institutions are forward looking and price in ~12M ahead of time, compared local European valuations that mainly look at previous 12 months. Banks usually provide very conservative targets (eg. 3 years for a 10x), but I do see potential for this company to be the next $LITE very soon. Europe should embrace positive-sum growth of their own companies that supply to hyperscalers. As their frontier companies provide back to locals through taxes, economic growth, and job growth.
It's highly nuanced, and I'll explain why it's not late, but late to some: Photonics is the newest supercycle (maybe H1 into H2 2025 was the start). Then there's many different architectural changes in each supercycle: -> $LITE, $COHR, Innolight, $AXTI and these names led the first I did a thesis post on mentioning all four of them as the largest beneficiaries (all are up 500-1000% 1Y) -> $AAOI, $JBL and others types of names are benefit immensely as the transitional bridge (eg. 1.6T pluggable) -> $SIVE, Celestial, Ayar, $POET are others future gens eg. CPO (what I'm focusing on now) -> VisEra, QD Laser, $ALMU and others are likely going to be future gens (quantum dot, different packaging types, etc) if you fast forward 4 years. Of course, $LITE does everything. $AXTI will be used for everything. But the amount of pure play exposure for each architectural shift in each mini supercycle is different. For example, inp usage with quantum dot is still there, but less used. Or DFB laser arrays for CPO instead of EML. There's probably still 50%+ with $LITE and $COHR. And you're a little on the "late" side of things. But you're extremely early to new architecture generations. What I'm trying to do is point regular retail investors into the direction of new gold mines for free. Before institutions figure out sooner or later by paying $20k for equity research reports.
All the hyperscalers $SIVE likely ends up in 2027-2028 is staggering at a $900m MC. Markets don't understand what's coming. From speculative mapping: > $SIVE -> $POET -> $MRVL -> 1. $AMZN (purchase agreement/warrants with photonic fabric from celestial) 2. $MSFT (maia) 3. $GOOGL (recent development talks with Marvell) $SIVE powers Poet Starlight/optical interposers, and Poet's CFO confirmed they're supplying to Marvell few days ago. > $SIVE -> $POET -> "NDAs other hyperscaler suppliers" 1. Western Hyperscalers > $SIVE -> $JBL (1.6T LRO)-> 1. $META (Jabil $INTC SiPH inheritance, maps to Meta LRO program) 2. $NVDA (NVIDIA possibly OEMs optical transceivers) -> $MSFT | AWS | hyperscalers $SIVE is the confirmed laser source for $JBL 1.6T optical transceivers. > $SIVE -> Ayar ($500m fundraiser last month for volume ramp) -> 1. Alchip (Joint CPO) 2. Intel 3. GUC/Wiwynn -> $AMZN (Alchip) -> $AMD (CPO from $GFS partnership) possible. $SIVE is known laser supplier to Ayar, and Ayar removed $MTSI / $LITE from their website recently. Only showing $GFS + $SIVE, likely showing Sivers was primary laser supplier. As $GFS x $AMD partnered up recently, that makes Siver a possible core laser supplier for $AMD's CPO program if they go with Ayar. > $SIVE -> Enablence -> O-Net (massive Asian OEM)-> Asian Hyperscalers 1. $AVGO ELS (possible) 2. $META and $GOOGL ELS 3. ByteDance (possible) -> ELS 4. Tencent (possible) -> ELS 5. Alibaba (possible) -> ELS $SIVE ELS partnership with O-Net/Enablence around OFC. Sivers lasers is mass produced by foundries like Win Semi... and they're validated in $GFS CPO supply chains too from their recent image presentations. It's not about what Sivers is forecasting today from qualification revenue that everyone models off of. Alpha comes from future revenue proportional to demand from every Western/Asian hyperscaler for CPO/1.6T in 2027, 2028, 2029, and onward. $SIVE looks like one of the most unknown photonic stocks on the market that's yet to come.
Oh wow, I missed this. That's probably why $POET is up 20.2% pre-market confirming "far in excess" of purchase orders on top of $MRVL supplier relationships. That translates materially to $SIVE laser production as well. Markets haven't fully priced in either yet imo.
Europe seems to be having a fun time from AI. $LPK +20.69% - (glass core substrates) +20.69% $IQE - 12.22% - (InP epiwafers) $SOI +11.02% - (silicon photonics substrates) $ALRIB +5.8% - (MBE / Quantum) Then there’s $SIVE down -4.7% from a local Swedish hit piece, while $POET is up 40%+ after Marvell supplier confirmation. But I’m very bullish on $SIVE since markets haven’t pieced together the connection to $POET and $MRVL yet. Regardless, Europe has something to be happy about from being important to American hyperscalers.
Woah... $POET is up 20.5% premarket today after a 19.32% gain. Mainly after the CFO's interview confirming they're the direct supplier to $MRVL. I wonder if markets know who the upstream laser supplier is yet? (hint: $SIVE). https://t.co/flfx9NVkxk
$MRVL in talks to develop $GOOGL TPU for two different chip models. High possibility $SIVE likely became the light source for Google's supply chains if talks go well. Especially as their custom ASIC likely pushes Celestial IP for scale up (Photonic Fabric) in the MPU's architecture. And this maps to both $POET and Sivers. Custom ASICs take years, so there's probably no material revenue from Google until H2 2028. Vendors are also probably multi-sourced, but having Google as a likely end user is a structural multi-year catalyst past 2028. Markets are typically forward looking.
Serenity's Follower Picked Hyperbolic 10x ETF Performance. Week 1: +12.39% $AEHR: +56.72% ($45.08 -> $70.65) $AAOI: +39.63% ($108.86 -> $152.00) $SIVE: +35.35% (9.9 SEK -> 13.4 SEK) $ENAFF: +31.58% ($1.71 -> $2.25) $AL2SI: +25.44% (28.70 EUR -> 36 EUR) $ENVX: +21.30% ($5.07 -> $6.15) $BZAI: +18.99% ($1.79 -> $2.13) $POET: +16.04% ($6.11 -> $7.09) $WATT: +14.81% ($15.8 -> $18.14) $HGRAF: +14.48% ($4.49 -> $5.14) $VLN: +13.79% ($1.16 -> $1.32) $LPK.DE: +13.20% (6.59 EUR -> 7.46 EUR) $FLY: +13.09% ($33.16 -> $37.50) $VPG: +11.63% ($44.7 -> $49.90) $PLAB: +9.86% ($40.87 -> $44.90) $TRT: +8.33% ($5.88 -> $6.37) $EQR.AX: +7.94% (.315 AUD -> .34 AUD) $LASR: +7.92% ($60.7 -> $65.51) $ASPI: +6.67% ($4.2 -> $4.48) $P4O.DE: +5.69% (6.85 EUR -> 7.24 EUR) $EOS.AX: +3.11% ($9.00-> $9.28) $ADUR: -0.29% ($10.37 -> $10.34) $MITK: -2.52% ($13.9 -> $13.55) $ALCJ: -3.41% (2.05 EUR -> 1.98 EUR) $TMC: -5.01% ($4.59 -> $4.36) $QURE: -9.94% ($17.21 -> $15.50) $EONR: -20.00% ($.9 -> $.72) Top 3: 1. $AEHR: +56.72% 2. $AAOI: +39.63% 3. $SIVE: +35.35% Honorable mention $ENAFF with a 31.58% return. Weighted average was 12.39%. Honestly not bad everyone, you beat year index returns in just 1 week.
When you go through the list of the leading CW laser companies from $COHR to $AAOI. It’s very impressive $SIVE stands out at $300m still… compared to the every other player in the billions. This is despite being the light source for $JBL 1.6T LRO optical transceivers and ~ $MRVL Celestial photonics program (now accelerated by $NVDA $2B investment). The sector from Furukawa to Yuanjie has been re-rated recently. But I do think markets missed this one, as they start volume ramp est. H2 (from $POET earnings) with multi year exponential TAM expansion from CPO and optical scale up. Downside risk is balance sheet, but I do think the likely Nasdaq listing for their photonics entity + scaling as the hyperscaler light source far exceeds current valuations. And will likely drive valuation premiums in a matter of time. We’ll see if this turns out right or not.
I get a sense of pride when I see a thesis playing out well real time. $LITE $371 -> $836 in the last 4 months. Not bad for a $58B company despite macro? This is while indexes and individual stocks. And photonic stocks like $POET and individual stocks like $RDDT dropped YTD. I tend to like laser companies the most from $SIVE, $AAOI, and Lumentum for photonics exposure. And in a better macro environment, I expect many of them to be up more than they are now.
Serenity's Followers Favorite Stock Parabolic Growth ETF: The most anticipated ETF of all time: $TRT - $5.88 $HGRAF - $4.49 $SIVE - 9.9 SEK $QURE - $17.21 $AEHR - $45.08 $ENVX - $5.07 $ASPI - $4.2 $EONR - $11.79 $LPK.DE - 6.59 EUR $MITK - $13.9 $EQR.AX - .315 AUD $WATT - $15.8 $VLN - $1.16 $BZAI - $1.79 $TMC - $4.59 $ALCJ - $74.57 $POET - $6.11 $AAOI - $108.86 $ADUR - $10.37 $P4O.DE - 6.85 EUR $PLAB - $40.87 $FLY - $33.16 $LASR - $60.7 $AL2SI - 28.70 EUR $ENAFF - $1.71 $VPG - $44.7 $EOS.AX - $9.00 I haven't heard of 1/3rd of these names, but if my followers have high conviction that their name will 10x... So do I.
Something that markets are finally starting to realize: Downstream: $NVDA invested $2B into $MRVL Celestial CPO program: $POET (Celestial’s Interposers): To ship 30,000 optical engines to ship this year from earnings today. $SIVE is the light source of Poet and Celestial for near/mid term Marvell photonics roadmap. Win Semi is the foundry for InP CW laser production. And even more upstream: $SOI / $AXTI for substrates and $IQE for epiwafers. This is the very start of the next photonics supercycle, at dirt cheap valuations. And it’s happening earlier than markets and institutions expected in 2026, with Nvidia frontrunning this entire shift. 99.9% of people see the changes happening downstream with Marvell, but don’t realize yet where the supply shocks will happen upstream.
Modest +1,124.09% return over the past year. Anon, only a few years left to escape the permanent underclass due to AI? OpenAI raising $122B is enough to fuel the rally for another 2 years. And new supercycles from photonics < $SIVE to $AAOI >, testing with $AEHR, $NBIS DCs, and advanced packing from $AMKR to $POET. Is just getting started.
I think I nailed the institutional bottleneck rotation. -> Caught the tail end of memory name rise with $SNDK, Samsung, SK Hynix, $MU -> Frontran institutions with photonics with names like $AAOI, $AXTI $LITE, $COHR. -> Doing it again now by adding heavily toward SiPh, ELS, and CPO: $SIVE, $TSEM, $SOI, $AEHR, Win Semi, and others. Of course if you want to play it safe: $MRVL (captive), $AVGO (captive), $TSM, and $NOK all do it as well, but they're larger players. And getting direct exposure to the next supercycle is ideal. I still think there's tons of room to grow for memory to EML optical transceivers, but the largest boom is at the start/inflection point of a new architectural cycle. Macro messing up some trades aside, expecting capital rotation soon toward CPO / ELS supply chains. TLDR from analyst note: The AI infrastructure investment supercycle follows a strict "bottleneck resolution" sequence: Compute/GPUs (2023) -> Memory/HBM (2024) -> Interconnect/Networking (2025+). Translation: "We judge that the third investment cycle of the AI value chain has officially begun. Following GPUs (2023) and HBM (2024), post-2025, optical interconnects will become the fastest-growing core segment. 2027–2028 will be a critical inflection point where CPO commercialization. 1.6T standardization, and Scale-Up optical transitions align, structurally expanding the TAM of related industries" Some takeaways: 1. CPO (Co-Packaged Optics) is moving from the lab to commercial mass production 2. 2027-2028 is the major structural inflection point (good idea to frontrun this now in 2026 from testing with $AEHR to ELS with $SIVE or packaging with $POET). 3. The Total Addressable Market (TAM) for optical components, materials, and testing equipment is expected to structurally expand 3x to 5x (I think this is sandbagging a bit).
It goes $SIVE -> Win -> $POET -> Celestial -> $MRVL basically. You just buy out the upstream light source and Marvell’s supply chain gets controlled for dirt cheap. They can engineer around it but qualification time and delays roadmap. Or $MRVL can secure a stake to make sure $SIVE remains independent
Can't $SIVE just pull a $LITE and TAM expansion down the ELS stack? I'm getting early stage $LITE flashbacks (Oclaro, NeoPhotonics, Cloud Light)... Here's my thesis/idea: on how Sivers can capture the ~$300-$400 ELS (from $50-100 arrays) and become a $10B+ company. How this plays out: -> Sivers is needs funding. -> Get NRE prepay or PIPE (eg. $AXTI/Northland) -> Say "Hey, $AVGO and $LITE are going to choke your custom AI cluster margins". ----> get $META / $AMZN / $MSFT capital injection for multi-source supply for next ASIC clusters cause they're scared. Esp. with $NVDA funding $4B to securing supply from $LITE and $COHR... then PTSD from the current EML capacity bottleneck. It's easier than people think. -> US spinoff of photonics arm (markets don't like investing in legacy companies). - - - - - > This will likely work in 2026, bc CPO/photonics is hot, now and not like 2024-early 2025. -> Raise enough to automate wafer probers and fund the module NPI. -> Fab-lite test model: develop probe cards and test inhouse, but push capex to OSATs. -> Buy SiPh packaging IP (or just continue JDM with O-Net and $POET) -> Keep their Glasgow InP fab for in-house testing for iteration/raw epitaxial. -> Outsource lithography, etching, etc. stuff to Win Semi + others (don't do capex heavy things yourself) -> Then just $SIVE can just hand tested lasers and packaging IP to $FN And Poof. You have a independent, mass producible, high margin, ELS module as ELSFP becomes standard. Then they can do other stuff like buying DSP designs and start consolidating the tech stack. Instead of cheap $10 laser dies x 6 for a $50-$100 laser array, you have $400 hot swappable modules. Basically their starting point is owning one of the chokepoints moat in photonics on the laser level... Then they can go downstream like what $LITE did with EML and optical transceivers. TLDR: Sivers ( $SIVE ) holds a rare, independent chokepoint in InP lasers at the exact moment the world is transitioning to CPO. There's only a few independent companies in the world that can do this like $SIVE (eg. Sumitomo, $LITE, $COHR). But of course they need the funding to achieve TAM expansion and the right vision.
Great callout on $HIMX and now down -31.54% (accelerated by macro). This is a good lesson around chokepoints. They missed two things on this "Meme Stock": - Chokepoints can be designed out. - Chokepoint may not be material enough to translate into revenue like $AXTI. $AAOI on the other hand, has material TAM increase if you look at optical transciever projections that they've been bearish on. Largely disagreed with a large number of photonics picks (eg. calling for $POET at 7x the valuation over $SIVE the laser supplier). Or being bearish on $AAOI without looking at optionality + revenue ramp in a massive TAM. But we'll see who's right or wrong in a years time, most of the recent drop across the board was accelerated by macro (not whether a $SIVE or $HIMX thesis was wrong). But very interesting to see chip designers go the other way of plays mentioned by analysts.
You cant spell Winner without Win. Because of that: I’m bullish on $SIVE supply chain. $SIVE -> WIN (TPE:3105) -> Ayar SuperNova -> $JBL -> Hyperscalers, as one flow. If you compare to $LITE and others that’s also in the same CPO CW WDM space. There’s a reason why: -> $POET / $MRVL Celestial. -> Ayar / $JBL and O-Net use $SIVE. It’s designed in as the light source for the next-gen photonics architecture for hyperscalers. At a ~$300M valuation. And I do think WDM DFB arrays are the superior architecture for scale up. And are incredibly hard to develop. It's not a zero-sum architectural game and will likely be split with how you handle scale out with single emitters like $LITE and $COHR. As well as captive suppliers like $MRVL and how they design their architectures. But if you look at the MC difference (~$300m with $SIVE, $55B with $LITE). Anyone can see how clear how valuable the $330M incoming disruptor in $SIVE is to the photonics space. And especially with the $4B foundry in Win Semi that captures fabless laser production from $SIVE, $AVGO, $MTSI and other players at scale. It’s highly asymmetrical to long both the supply chain as exposure to where photonics and hyperscalers architecture are heading.
$SIVE has gotta be the highest upside stock I’ve seen in this market since $AXTI? No way markets missed the CW laser light source for Jabil, Marvell (Celestial via $POET), O-Net, Ayar ( $NVDA, Mediatek backed)… At a $140M valuation. ($350m now) Not only do you get the most direct laser exposure to future CPO scale up? But also this cycle’s 1.6T pluggables with $JBL (formerly Intel Silicon Photonics division) coming soon. With Win Semi bridge capacity scaling needed for hyperscaler supply chains. Don’t think 99.9% of people realized the sheer scale of this yet.
< $SIVE | $SIVEF > at a ~$250M valuation looks like one of the most severe structural mispricing in the optical semi market. $LITE and $COHR, have $45B+ valuations today: Largely because of their control over EMLs and VCSELs that they ship to -> InnoLight and Eoptolink. For current pluggable transceiver supercycles. I will keep hammering this home until markets understand: Sivers has replicated this exact, highly lucrative merchant-supplier model for the next paradigm: -> CPO and ELS. And also: -> Lasers that a massive manufacturer like Jabil is using for the current 1.6T upgrade cycle. Sivers saw architectures shifting away from EML and became the pure play supplier for CW. Current Cycle (Pluggables): LITE/COHR supply EML -> InnoLight/Eoptolink build modules -> $GOOGL, $META, $MSFT, $AMZN buy them. Next Cycle (CPO / ELS): Sivers supplies CW DFB -> $POET, Ayar Labs -> flows to hyperscalers like $AMZN, $META, $MSFT and others. However, instead of building up mega fabs with yield/capacity ramp risk: They transitioned to an outsourced, fabless model for high-volume CW Lasers with Win Semi and effectively de-risked scaling. So why does it have a $250M valuation during the photonics supercycle? My opinion: 1. Nobody knows about it yet. 2. Many fund mandates prevents them from buying small caps in Sweden However, when you start looking at obscure upstream names in hyperscaler light supply chain: At the top for the light source sits $SIVE. A small $250M company among $MTSI, $LITE, $COHR, Sumitomo and the $10B-$40B+ incumbents. Again... A $250M company: Powers Jabil's 1.6T LRO optical transceivers modules. Jabil is massive. As well as Ayar, $POET, Enablence/ $ONET and many other names now (that are not disclosed) for diversification. $SIVE found their way to scale as the lightsource of hyperscaler supply chains for future photonic architectures. And looks incredibly undervalued, relative to forward TAM expansion and ramp.
The Serenity Silicon Photonics / CPO ETF. YTD Returns of Each Index Stock: $IQE: +282.5% $AXTI: +246.6% Landmark: 167.54% $AAOI: +157.37% $SIVE: +113.08% $SOI: +103.54% $LITE: +100.27% $LWLG: +92.35% $VIAV: +88.71% $AIXA: +73.92% $AEHR: +70.4% $CIEN: +67.67% $FORM: +60.67% $FOCI: +60.44% $CAMT: +49.13% $GLW: +46.77% $SMHN: +45.94% Fujikura: +43.89% $COHR: +41.81% $KEYS: +40.48% $TSEM: +36.42% $ASX: +29.89% $MTSI: +28.34% $NOK: +27.5% Shin-Etsu: +27.33% $ONTO: +26.28% $BESI: +24.71% $UMC: +18.11% $INTC: +17.27% $OXINF: 15.03% $FN: +12.79% Eoptolink: +11.82% $TSM: +6.00% $HIMX: +5.39% $SMTC: +4.11% Sumitomo: +3.67% $CSCO: +3.25% Innolight: +.33% $MRVL: +.16% $APH: -6.48% $MXL: -7.62% $AVGO: -7.99% $POET: -12.99% $TEL: -14.93% This is retrospectively, but as you've known I've been in a lot of the winners for awhile (eg. Top 6/7 like $AXTI or $LITE aside from Landmark). However, if you were curious if you invested in the photonics trend as a whole at the start of the year. The equal weighted return? 50.033% I expect the Photonic Supercycle to last over the next several years, and many of these names to be large beneficaries going forward. Especially as CPO is used to scale AI deployments. Photonics is the new architectural paradigm for AI.
Sivers is up another 29% to a $282M marketcap today. I genuinely think $SIVE could be the next $LITE. As they’re positioned as the light source for the next generation of hyperscaler supply chains. When scale up-scale out architectures transition to CPO & Silicon photonics. For the start of next Photonics Supercycle. The companies that buy and package their laser arrays/cw dfb lasers from $POET to Ayar? Are worth ~$1B-$4B+ (not including o-net or undisclosed). With current pluggable transceiver cycles: Laser suppliers typically command higher valuation premiums than their packaging counterparties that buy the light source. So, I do think $SIVE is largely undiscovered by markets and far from being priced in.
I feel like markets should value: $AAOI $93 -> $162 (~$13B MC) after their new capacity projections today. and $SIVE should be valued at 7.7 -> 38.5 ($1.1B MC) at least? If one is ramping to ~$1.97B capacity EOY 2027 (which is basically revenue, since hyperscalers are buying anything they can make) Then the other is the likely laser supplier to hyperscaler supply chains from $AMZN Trainium to $MSFT Maia Clusters? At the very least, should price in forward revenue growth. This is including execution uncertainty, and without premiums assigned to others like $LWLG at $1.1b+. If Win semi qualifies $SIVE and $POET/Ayar/and others scale up. I feel like $SIVE valuation could easily 20x-30x from here? If $AAOI hits $378M/month projections, could easily 5x from here to a ~$30B MC. These possible price targets is how insane the optical supercycle is (like memory), but largely depends on how each company can execute.
$SIVE is the upstream laser supplier for CPO and Silicon Photonics. They're the likely $COHR / $LITE type future light source for: - $AMZN Trainium Clusters - $MSFT Maia Clusters and possibly other hyperscalers like $META MTAI and $GOOGL TPU clusters. At a ~$200M MC. Relational Mapping (speculative): $SIVE (light source) -> $POET (optical interposers) -> $MRVL (Likely Celestial Captive) -> $MSFT Maia + $AMZN Trainium. $SIVE (light source) -> Ayar -> AiChip -> $AMZN Inferentia/Trainium $SIVE (light source) -> Enablence -> O-Net -> ? Asia Hyperscalers _ Ongoing: $SIVE (light source) -> Ayar -> GUC -> ? (Google $TPU) $SIVE (light source) -> Ayar (TeraPHY/SuperNova)-> Wiwynn (captive CPO) -> ? ( $MSFT, $META historically Wiwynn's largest clients). Because of captive models like $MRVL Celestial, they get a free ride. However, they do compete multi-source ELS against Lumentum, Coherent, and $MTSI with Ayar and win anyway in merchant models. But they win either way. For high-volume production ramp up, a large part of it depends on the ongoing Win semi qualification, but this will likely be a large indicator. Again supply chain BOM is extremely confidential. $AMZN will never tell anyone "Hey, we use $SIVE ". But if you put 1+1+1+1+1 together, you can piece together the likely suppliers. Most people see "Poet Starlight" uses $SIVE. Or Ayar uses $SIVE. But don't map all the multi-hop relations to see where they end up. I do think $SIVE is an extremely undiscovered opportunity as the next possible mini $LITE for Silicon Photonics at $200m MC. As they're the likely upstream laser supplier for hyperscaler supply chains for future CPO/Silicon Photonics scale up with cw dfb lasers and scale out with laser arrays.
The upcoming CPO / Silicon Photonics Bottleneck Cheat Sheet: $SIVE, Sumitomo, $LITE, $COHR, $AVGO, $MTSI, $AAOI - Light Source (CW DFB Lasers) $TSEM, $GFS, $UMC, $TSM, $INTC - SiPh foundry $NOK, $CIEN, $CSCO, $COHR - DCO $HIMX, FOCI (3363.TWO) - Micro-lens + Fiber Arrays $POET - Optical Interposers $SOI, $AXTI, Shin-Etsu - Substrates $FN, $ASX, Innolight, Eoptolink - Optical Packaging and Assembly $MTSI, $SMTC, $MRVL, $MXL - Analog/Mixed-Signal ICs $LWLG - Speculative Modulator Materials. $GLW, $APH, $TEL, $FIT, Fujikura - Connectors and Fibers $FORM, $KEYS, $VIAV, $AEHR- Test & Measurement $BESI, $SMHN, $ONTO, $CAMT - Advanced Packaging & Hybrid Bonding Many are private companies from Lightmatter, Ayar, Ranovus and others. Now... Everyone is asking... How do you profit? If you look at the forecast for CPO TAM, it's a straight line up, and next year is inflection point for CPO mass deployment. The alpha is capturing the rotation: From the current EML bottlenecks ( $LITE, $COHR type) to SiPh / CW DFB architectural winners for CPO. Highest upside potential are the ones that aren't included in current cycles. But that are in the next. Companies like $SOI, $SIVE, or $AEHR are perfect examples. Ride the current pluggable bottleneck like $AAOI. But the alpha is frontrunning institutions with the next CPO bottleneck. The capital rotation is inevitable.
Just in: $SIVE announces major partnership with O-Net and Enablence for CPO. Sivers will be the laser array supplier for CPO. This is thesis validation in effect as $SIVE becomes InP CW DFB supplier for silicon photonics. In simpler terms, this is the $LITE -> $FN relationship for current optical bottlenecks. And mirrors the existing $POET -> $MRVL Celestial CPO supply chain, but in Asia. Enablence makes the "Star Coupler", similar to $POET interposers. O-Net is a massive assembler, that packages them for the finished module. O-Net in HK is a supplier to companies like Huawei, ZTE, Ciena, Nokia, Fujitsu, and more.
$SIVE is now up +73.78% today ($231M MC). As markets price in information synthesis of the next potential $LITE of photonics. If I had to explain the difference: One laser source in Lumentum primarily benefits from current optical bottlenecks. The other in $SIVE is for the upcoming CPO/Silicon Photonic bottleneck. Lumentum is largely benefiting right now from $NVDA and hyperscalers securing capacity of EML lasers for current pluggable optical transceivers cycles. As seen with the current EML bottleneck, hyperscalers are buying out any 800G/1.6T transceiver + upstream capacity from: - $AAOI (in-house) - $COHR, $LITE (EML lasers + design) -> $FN (assembly) - $COHR, $LITE (EML lasers) -> Innolight / Eoptolink What's next? Silicon Photonics and Co-Packaged Optics. The architectural shift to CPO requires massive arrays of high-power CW DFB lasers. And this would likely trigger a complete, sudden paradigm shift in volume demand. $SIVE benefits from InP CW DFB lasers for SiPh and CPO: The up and coming companies like: $AYAR, $POET source $SIVE lasers, but primarily do advanced packaging. Then they feed up to larger companies like $MRVL Celestial (that buy $POET's interposers). However, if you go upstream, the light source is $SIVE. CW DFB lasers are light engine ( $SIVE ); the silicon photonics package ( $POET and others) is how it gets transmitted. CPO scale is not there yet. But we know it's coming. And as seen with current optical transceiver cycles: - Light sources from $LITE and $COHR demand much higher valuations than companies like $FN that focus on advanced packaging. Markets have been focusing on $POET, but missed where they get the actual $LITE type light source for Starlight. The risks are present including facing multi-source competition with $LITE, $COHR, $AVGO, and others. So again, make sure to do your own research. But my argument against that: Sivers been early enough to tailor custom lasers to fit $POET, Ayar, and other specifications before they got popular (sort like the $POET to $MRVL Celestial analogy). There's volume risks as well: But the potential Win Semi qualification offsets that. Dilution risk to scale capacity, is always present with every early-stage company as well. I did my thesis on $LITE last year and still love the stock for Google TPU ramp/OCS. But this year, I'm focusing on: $SIVE, as my personal CW DFB laser exposure for the new photonics architectural shift. I’m sharing my own thoughts on capturing the rotation from the current EML cycle to the upcoming CW DFB/Silicon Photonics cycle.
$SIVE is now up 50%+, to a $190 million USD MC (~1.8B SEK -> USD). However, I genuinely believe this could be the next $LITE for silicon photonics/CPO. And I’m holding shares, as my personal bull case scenario is $10 billion+. As Sivers sits in the silicon photonics CW DFB laser bottleneck of the next gen photonic architectures spearheaded by $NVDA. This is compared to how $COHR / $LITE EML lasers are the current optical transceiver bottleneck. They’re already the laser supplier to Ayar, $POET (buys $SIVE lasers -> advanced packaging into optical interposers), and likely other silicon photonics/cpo players The Win semi ongoing qualification is one of the biggest bull cases, as this allows them to scale up capacity. Time will tell if this thesis turns out to be correct but I personally think this name is widely undiscovered. This is my own personal thesis and I’m not recommending anyone to tag along. But if you DYOR, maybe you’ll come to the same conclusion I did that $SIVE looks like the next $LITE.
I’m long $SIVE at $140M. I believe this is the next $LITE that markets and institutions missed. $SIVE makes InP CW DFB lasers. Closest comparison is $LITE in the current EML laser bottleneck. But instead of supplying to Innolight/Eoptolink for current optical transceivers cycles. They supply the lasers to $POET Starlight, Ayar SuperNova. And others for the future CPO/silicon photonics architectures spearheaded by $NVDA. Current valuations make 0 sense to me personally. $POET is advanced packaging for $SIVE type lasers… But $POET commands worth 11x+ more than the company making the laser itself? It’s feels like valuing a more advanced $FN (~$20B) packaging at $400B when $LITE is valued at $40B. So now at $130m: - - You have a likely mini $LITE like laser supplier to Marvell Celestial + hyperscalers through $POET. - Laser supplier to Ayar ( $NVDA, $INTC ), though they do multi source with $LITE, Sumitomo, $MTSI. And other potential up and coming suppliers potentially like Lightmatter that they’ve name dropped (eg. Q2 2023 earnings). This is unconfirmed but supply chain BOM is confidential. On top, for revenue, they expected $453M "pipeline next few years”. And, they have capacity expansion through WIN: “Win Semi foundry qualification in progress for volume production from Laser designs from Sivers." Sivers feels the silicon photonics/CPO version of $LITE, with actual rapidly growing customers like Celestial through $POET, Ayar, with more to come. I wouldn’t have liked it last year, but just 3 weeks ago, they refinanced all their debt successfully to $12M convertible loan (10.85%) and a $5M term loan (12%), which cleans up debt. It’s $17m total, which feels like nothing to US markets when $AAOI is doing a $500m ATMs every other week. Best of all, this is their pure play inp laser segment for silicon/photonics + cpo. Their Lidar segment is ramping up and they have $53-138M projected revenue coming in. Downside risk: - execution (as always) - dilution to scale up capacity to compete with $LITE and others. - $LITE, $COHR competition on scale after $NVDA just gave them $4B - CPO ramp gets delayed. I have no clue how, $LWLG, a pre-revenue science project with $TSEM, is valued at $1B+ MC. Or how $POET, is worth ~9-10x more than its laser supplier. When $SIVE, the mini $LITE equivalent for CPO/Silicon photonics, is valued at $140M. I do believe this is largely undiscovered by institutions, since this is some random company in OMX Nordic Exchange (similar to micro $AXTI before I started posting about the inp substrate bottleneck). But I do think it will get a lot of institutional attention as Celestial and Ayar scale up. Especially if $POET and $SIVE gets qualified with other customers. If CPO completely replaces pluggable transceivers in the next generation of hyperscaler architectures. Sivers, with possible WIN Semi qualifcation and if they become the multi-source lasers for NVIDIA, Marvell, Intel, and Broadcom architectures, can be strongly rerated. Just as how $LITE did today going from $16 -> $622. This is just my personal thesis I'm sharing, DYOR/NFI. TLDR: InP Lasers are the current bottleneck in photonics as seen with $LITE valuations. $SIVE looks like the mini $LITE for the upcoming CPO/Silicon Photonics ramp. I personally took long position in $SIVE, as I believe they’re a large beneficiary of the upcoming silicon photonic/CPO architectural changes by $NVDA (with GTC cataylst). The upside here just way too compelling for me personally as the next possible $LITE.
This is my hot take: Neoclouds like $NBIS or $IREN would command 1.3X higher valuation... If they renamed their datacenters to something cool. Cool Name Examples: - $POET "Starlight" - $NVDA "Blackwell" But datacenters? - $IREN "Prince George" - $CIFR "Barber Lake" Why are you naming an AI datacenter after your hair cut stylist or a British Kid nickname? I swear, nobody outside existing investors are going to hyped over Iren's "Prince George" datacenters coming online. But if everyone see's $NBIS "Singularity" AI DC coming online, that just sounds badass. Nebius would be worth $40B by now.
I've been the first few to cover many supply chain photonic names. Most are up 100-400%+ since I've posted. Here's the TLDR overview of my thesis posts: “Safest” Longs as of Today: - $TSEM (Tower Semi) - $SOI (Soitec) - $COHR - Defensible compounders over time. Soitec - Substrate monopoly over silicon photonics / CPO architectural ramp at dirt cheap valuation (after recent 40%+ rise maybe still 1.4x book) Tower Semi - P/E in the 10's for 2028, 70%+ capacity booked already, $NVDA architectural partner, and basically the pure play $TSM of photonics. Coherent - Basically does everything from materials/substrates to lasers to transceivers in photonics. As well as fundamental supplier to many other verticals. Most High Beta/Extreme Growth Longs: $AXTI - InP duopoly with Sumitomo (that getting export controlled), upstream feedstock duopoly with Vital. Basically at the top of the entire photonics food chain is AXT. There's certainty export control risks, but my thesis is that if AXT goes down, the photonic buildout with AI goes down. So might as well go long on AXT. $AAOI - 10x revenue ramp into 2027. Laser -> Design -> Assembly, Made in America. Main uncertainty is execution, scaling laser capacity that they've bought from $COHR, etc. Demand from hyperscalers are all there. Can they deliver? I'd take the risk. $IQE - Basically completely dependent on restructuring and clearing debt (~$200M MC). Known $LITE supplier for epiwafers, and their main competitor was Landmark with a $3.5B+ valuation. The latent capacity is there with reactors, but they basically need to pull off a successful pivot over to photonics and cut off legacy drag for 10x rerating. Highest risk out there, but maybe worth the reward.s Long $GOOGL TPU Ecosystem: $LITE - Basically very high BOM related to optical due to OCS monopoly for Google. If you think Google TPU is a trillion dollar program that might end up like $NVDA, go long on $LITE. Google has $175-180B capex planned for 2026, and their CTO for AI Infra said they plan to up that Y/Y, probably spending $1 trillion in the next 8 years. If that holds up, $LITE is extremely undervalued relative to forward potential. Of course the supply lasers to other hyperscalers too, but I'd say it's more heavily tethered to Google growth. _ There's a ton of others out there I've covered like: $POET - I'm personally not long, but $400M balance sheet gives it good cushion. Just found Celestial from $MRVL ramp was too far out, eg. $500 million 2028, $1 billion 2029 projections, for revenue to be too material as of 2026. It largely depends if their interposers get other hyperscaler qualifications rather than backdooring through Marvell, which was the main bull case. $HIMX- I did find this thesis to be slightly compelling as a likely $TSM COUPE supplier. But personally, I preferred $SOI, and would just put more concentration into that (since Soitec known supplier already to basically everything silicon photonics, and is just coming out of a downturn). There’s a lot more like $NOK, $SHMN, that are interesting, but I’ve personally out concentration into the ones I find most compelling. As “crowded names” like $LITE, it does not mean there’s no upside left. It just happens to be more priced in until there’s new news. There's a lot of "critical suppliers" but there's a difference between importance in the supply chain... And converting that into extreme revenue growth eg. $AAOI -> $4.5 billion in revenue. But for TLDR photonics exposure, my portfolio looks similar to this: High Concentration (Safer) $TSEM foundry, $SOI substrate, $COHR everything Mix of Long + CSP (High Volaility): $AXTI substrate/feedstock, $IQE epiwafer, $AAOI transceiver supply chain Then Long Google with $LITE
$AAOI files for another $250 million USD ATM, upping the amount to $500 million. The positive note is: $AAOI has already finished their first ATM. Markets absorbed $250 million in selling pressure (likely ~$100 before the stock went to $120) and the stock increased anyway. “The amendment states that 2,476,307 shares have been sold for gross proceeds of approximately $249,999,983 under the sales agreement as of March 12, 2026” However, I’m extremely bearish when it comes to excessive ATMs for any company like $IREN or $POET, and it’s not inclusive to $AAOI. $500 million for capacity expansion is likely accretive compared to other $6 billion ATMs if people want to wait it out. That being said, not happy about it and if they needed $500 million, should have done it from the start.
Uhh, from my own personal research so far, to cover all grounds I’ve liked: 1. $AXTI at the very bottom of the entire supply chain + 1/3rd of InP substrates 1/4th of InP. Completely unheard of that AI supply chain is tethered to this $700m stock. 2. $DOWA + Sumitomo Electric for Western Hedge on substrate + materials. 3. $AAOI, $LITE for hyperscaler chips, one for $AMZN/ $MSFT, the other for everything but more levered to $TPU 4. $MRVL + $AVGO I think that’s kind of all you need to capture photonics BOM value + InP supply shock. There’s some other interesting ones like Landmark Opto that I’m looking at now. $POET didn’t quite make that list and you’d be getting exposure through $MRVL anyway, unless there’s something I missed
Agreed, for traders, this should be an interesting opportunity like Lithium in 2021 when EVs came about or HBM currently with Sk Hynix and Micron if people recognized the bottlenecks early. Tons of opportunity ($AAOI only up 2.9% YTD despite new hyperscaler orders. Tied to hyperscaler deployments like Maia/Tranium). $MRVL with extreme demand but mainly in q4 2026, into 2027 from Maia, down 22% YTD. And $POET as an indirect beneficiary of $MRVL ramp too. Shortages throughout the entire supply chain with InP substrates. $GOOGL ramping up TPU which benefits $LITE and vertical integration + record backlog from $COHR Extremely absurd players like $AXTI with a $700m marketcap basically being the single point of failure for the future AI ramp. Not quite sure how you place a value on that lol. $COHR, $LITE and substrate providers are hitting the capacity limits now. We’ll see how much time it takes for his to go to the extremes like memory.
@crux_capital_ Thanks, love your posts on $LITE, $POET $AAOI $COHR, $MRVL, and other photonic players too
@Plaskpojken I don't know anything about $SIVE yet. $POET isn't exactly a big name yet so by derivative, Sivers likely wouldn't be a major player. But I'll give it a look.
For me personally: A stock is "high conviction" when they are fundamentally de-risked and are going from that point to scale. For example, $NBIS post-MSFT deal. I like $AAOI much better than $POET in the photonics space personally. But neither of them are "de-risked yet". So Poet as you mentioned, benefits from Celestial, which got acquired $MRVL. Marvell basically sells Poet's interposer via Celestial to hyperscalers for connecting tpus/trainium. But this is via multiple hops away. $AAOI already had direct hyperscaler contracts like $AMZN for Trainium + $MSFT for Maia. And equity agreements like what $ALAB has for Amazon. However, they're fully vertically integrated + built in Texas. They have a pretty big potential to 10X if they can get the whole supply chain to scale in America + perfect execution. But because they're at lower scale compared to $COHR, $AAOI has huge execution risk + it's not high-conviction. Same with $POET, there's no de-risking factor yet that would make me fully convinced. However, Poet and AAOI are both photonics plays that can 10x, which is why I have some $AAOI in my portfolio, but neither are high conviction.
I've looked into $POET but didn't like it as much compared to $AAOI given AAOI already has direct hyperscaler customers with $MSFT and $AMZN. $POET had Celestial that got acquired $MRVL, where Celestial used poet’s interposer to connect tpus/trainium, and Marvell sells that to hyperscalers. But it's not quite the same de-risking few hops away as direct massive volume orders from $AMZN and $MSFT and equity agreements that Amazon has like they did with $ALAB. Amazon has a financial incentive in $AAOI like $ALAB, but Astera is already a $30B company, while AAOI is a $2.5B MC.